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Nanoparticles (particles sized between 1 and 100 nanometers) are more and more used in all fields of science and
medicine for their physicochemical properties. As gold has traditionally been considered as chemically inert and
biocompatible, in particular, gold nanoparticles have been established as valuable tools in several areas of
biomedical research. But in contrast to the multitude of studies that addressed the clinical use of gold
nanoparticles, only little is known about potential toxicological effects such as induction of inflammatory immune
responses, possible apoptotic cell death or developmental growth inhibition in embryos. Therefore the present
study performed a systematic review of toxicological data, especially experimentally acquired data concerning
in-vivo-toxicity, published in the PubMed. It can be stated that the data in this area of research is still largely limited.
Especially, knowledge about size-, charge- and surface-chemistry dependent in-vivo-toxicity is needed to predict
the hazard potential of auric nanoparticles (AuNPs) for humans.
Keywords: Gold, Auric nanoparticles, Toxicology, In-vivoNanoparticles, also called ultrafine particles, are defined as
particles sized between 1 and 100 nanometers (10-9m) and
form a bridge between bulk materials and atomic or mo-
lecular structures [1]. They occur in nature in the context
of volcanic eruptions or any natural or anthropogenic
combustion process. Man-made nanoparticles may appear
for example as globular carbon molecule (fullerene or
“buckyball”), as branched ribbons (dendrimers) or as nano-
tubes [2]. For gold has traditionally been considered inert
and biocompatible, its physicochemical properties and
high surface area, gold nanoparticles (AuNPs) are more
and more used in biomedical research [3]. AuNPs of vari-
ous sizes and morphologies have attracted considerable
interest for medical applications for example as carrier for
drugs such as paclitaxel [4], as tumor-detector [5], photo-
thermal agent or radiotherapy dose enhancer (Figure 1)
[6-8]. Nevertheless, experimental use of AuNPs presented
possible medical hazards as the surface to volume ratio
causes catalytic properties and can make particles very re-
active [9]. Furthermore, Nanoparticles easily pass cell
membranes and can interact with intracellular metabolism
(Figure 2) [10]. As at nano-scale gold-particles may exhibit* Correspondence: gerber@med.uni-frankfurt.de
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reproduction in any medium, provided the orsize-related properties that differ significantly from the
known properties of non-nano-scaled gold-particles, one
cannot predict reliably the nature of AuNPs and a biologic
system and interactions between AuNPs and living cells
[11]. Beside the size, further potentially toxic features of
AuNPs depend on charge and surface-chemistry. To gen-
erate an overview of gold nanoparticle-induced toxicity,
we performed a systematic review focused of toxicological
data published in the PubMed.
In a recent study, Conde et al. [12] assessed gold nano-
particles (AuNPs) for aspects of genotoxicity and cell
toxicity. The authors constructed an Antisense Gold-
nanobeacon consisting of a stem-looped oligonucleotide
double labeled with 3'-Cy3 and 5'-Thiol-C6 and tested for
the effective blocking gene expression in colorectal cancer
cells. They also studied this system for the proteomic effects
of gold-nanobeacon exposure to cancer cells. Exposure
was evaluated by two-dimensional protein electrophoresis
followed by mass spectrometry to perform a proteomic
profile and MTTassay, Glutathione-S-transferase assay, mi-
cronucleus test and comet assay to assess the genotoxicity
[12]. Overall, the authors concluded that the proposed
nanoparticle strategy does not exhibit significant toxicity
[12]. Upon studies in vitro have demonstrated, that surface
chemistry plays a crucial role in determining toxicity ofLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Common medical applications of gold nanoparticles.
Figure 2 Aspects that contribute to the hazard potential of AuNPs.
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charge and size on AuNPs in in-vivo toxicity using an em-
bryonic zebrafish model and found out that the surface
functionalization dictated toxicity outcomes with embryos
[14]. In this study, exposure of zebrafish embryos to 1.3
nm AuNPs functionalized with a monolayer of the cationic
ligand, N,N,N-trimethylammoniumethanethiol (TMAT-
AuNPs), emerged as highly developmentally toxic, causing
embryo lethality and numerous morphological effects as
abnormally small and underpigmented eyes [14]. Exploring
the mechanism underlying this effect, the scientists deter-
mined that TMAT-AuNPs caused a significant increase of
apoptotic cell death in the eye and aberrant expression of
transcript factors that regulate eye- and pigmentation de-
velopment (pax6a, pax6b, otx2, and rx1) and pigmentation
(sox10). Embryos exposed to sublethal concentrations of
TMAT-AuNPs showed hypoactivity and axonal growth in-
hibition. The authors come to the conclusion that TMAT-
AuNPs may pose a developmental hazard to mammals
[14]. Also using an embryonic zebrafish model, Truong
et al., from the Oregon State University, investigated how
surface functionalisation and charge of AuNPs influence
molecular responses in vivo, utilizing dechorionated em-
bryonic zebrafishs, exposed to AuNPs from 6 to 24 or 6 to
48 h post fertilization [15]. The authors used precisely
engineered AuNPs with 1.5 nm cores and functionalized
with three ligands: 2-mercaptoethanesulfonic acid (MES),
N,N,N-trimethylammoniumethanethiol (TMAT), or 2-(2-
(2-mercaptoethoxy)ethoxy)ethanol. The scientists con-
firmed AuNP uptake in exposed embryos using inductively
coupled plasma-mass spectrometry. Developmental assess-
ments revealed differential biological responses for each
NP type when embryos were exposed to the functionalized
AuNPs at the same concentration [15]. TMAT-AuNPs
were lethal to embryos, MES-AuNPs induced sublethal
malformations and MEEE-AuNPs did not induce any
in vivo biological response. Effects of MES- and TMAT-
AuNPs in exposed embryonic zebrafishs included inflam-
mation, immune response and misregulation of transport
mechanisms. The authors conclude that surface functiona-
lization of AuNPs influences the biological response at the
phenotypical and molecular levels.
The long-term effect of exposure to AuNPs during em-
bryonic development was investigated also by Lisa Truong
et al. in a zebrafish model one year ago [16]. In this study,
the scientists wanted to identify whether acute exposure to
negatively charged 2-mercaptoethanesulfonic acid- (MES),
or neutral 2-(2-(2-mercaptoethoxy)ethoxy)ethanol- (MEEE)
or positively charged trimethylammoniumethanethiol-
(TMAT) AuNPs would lead to deleterious effects that per-
sist into adulthood and specifically, whether the charged
surface functional groups would impact development of
the central nervous system leading to abnormal behavior
or survivorship in adulthood. Therefore zebrafish embryoswere acutely exposed to the three gold NPs with differing
surface charge. The scientists found out that both MES-
and TMAT-AuNP exposed embryos exhibited hypo-
locomotor activity, while those exposed to MEEE-AuNPs
did not. Evaluation of behavioral abnormalities and the
number of survivors at 122 days post fertilization showed
that both treatments induced abnormal startle behavior
following a tap stimulus [16]. But the group exposed to
the negatively charged MeS-AuNPs also exhibited abnor-
mal adult behavior in the light and had a lower survivor-
ship into adulthood. The authors sum up that exposure to
NPs differing only in the functional group, affects larval
behavior, with behavioral effects persisting into adulthood
[16]. Using Drosophila melanogaster as model organism,
another study is also concerned with the long-term geno-
toxic and mutagenic effects of AuNPs in vivo. Vecchio
et al. from the Italian Institute of Technology, have shown
in a recent work that exposure to AuNPs may lead to sign-
igicant phenotypic modifications in Drosophila melanoga-
ster which even may be transmitted to the progeny [17].
Via treatment of Drosophila melanogaster for an entire
life-cycle (eggs-to-eggs) with citrate-capped 15 nm AuNPs
which were formulated in the diet at a dose of NP to the
flies 3 μg/g per day, the scientists obtained the first
nanomaterial-mutated organism, named NM-mut. In-
creased levels of reactive oxygen species are discussed to
be the underlying mechanism for the observed variations
in the genome-wide expression profile induced by AuNPs
[18]. Compared with the descendants of non-treated or-
ganisms, the mutated flies reveal impaired fecundity and
fertility, as well as morphological defects of the wings an
of the eyes. The Authors conclude that 15 nm AuNPs are
able to induce genetic mutations in the germinal line of
Drosophila that may be transmitted to the progeny [15].
In another recent publication concerning the surface-
dependend toxicity of AuNPs, Fraga et al. investigated the
cytotoxic effects of AuNPs in human liver HepG2 cells.
The Portugal scientists utilized ~20 nm spherical AuNPs
(0-200 μM Au) with two surface coatings (citrate (Cit)
compared with 11-mercaptoundecanoic acid (11-MUA))
[19] and evaluated cytotoxicity, via 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction
and lactate dehydrogenase (LDH) release assays after 24
to 72 h of incubation and assessing DNA damage by the
comet assay, 24 h after incubation with the capped
AuNPs. Quantification by graphite furnace atomic ab-
sorption spectrometry and transmission electron micros-
copy revealed that both AuNPs were internalized in a
concentration-dependent manner and no differences were
found in the extent of the internalization between the two
types of NPs. Furthermore, both differently coated AuNPs
did not induce significant cytotoxicity [19]. But in spite of
absent cytotoxicity, the authors observed genotoxic effects
of Cit-AuNPs, namely inversely proportional to the tested
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exposed cells [19]. In summary, the authors point out the
importance of the surface properties to increase the bio-
compatibility and safety of AuNPs. AuNP-mediated hep-
atotoxicity in mice with healthy or damaged livers was
examined by Hwang et al. in a recent study in south
Korea, using a mouse model of nonalcoholic steatohepati-
tis (NASH) [20]. The searchers induced a model of liver
injury by feeding mice with a methionine- and choline-
deficient (MCD) diet for 4 weeks. After lateral tail vein
injection with 5mg/kg 15-nm PEGylated AuNPs in MCD-
diet-fed mice and normal- fed mice, sizes and biodistribu-
tion of the AuNPs were analyzed by transmission electron
microscopy, levels of alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) were estimated with an
automatic chemical analyzer, activities of antioxidant en-
zymes were determined by biochemical assay and liver
sections were subjected to pathological examination. The
authors observed that AuNPs significantly elevated the
serum ALT and AST levels in MCD diet-fed mice com-
pared to MCD diet-fed mice injected only with mPEG
(methylpolyethylene glycol). Furthermore, severe hepatic
cell damage, acute inflammation, and increased apoptosis
and reactive oxygen species (ROS) production were ob-
served in the livers of AuNP-injected mice on the MCD
diet [20]; whereas these liver injuries were attenuated in
mice fed a normal chow diet. The authors suggest that
AuNPs display toxicity in a stressed liver environment by
stimulating the inflammatory response and accelerating
stress-induced apoptosis [20]. They recommend consider-
ing health conditions, including liver damage, in medical
applications of AuNPs.
The importance of understanding electrostatic interac-
tions between charged nanoparticles and monolayers as
model membranes to predict interactions between nano-
particles and living cells in the future, was quite lately con-
sidered also in Portugal by Torrano et al. [21]. The authors
showed how oppositely charged gold nanoparticles (Au-
NPs) interact with monolayers of the zwitterionic dipalmi-
toylphosphatidyl choline (DPPC) and negatively charged
dipalmitoylphosphatidyl glycerol (DPPG). For this purpose
they spread monolayers on subphases containing two con-
centrations of either negatively charged Au-NPs coated
with citrate anions or positively charged Au-NPs function-
alized with the cationic polyelectrolyte poly(allylamine
hydrochloride) (PAH). The charged nanoparticles had re-
markable effects on DPPG monolayers which were ob-
viously larger for the positively charged AuNPs. But
negatively charged ones also affected the monolayer prop-
erties owing to the influence of counter ions. The in-plane
elasticity for DPPG monolayers within the surface pressure
range corresponding to real cell membranes increased with
adsorption of positively charged NPs, but decreased with
the negative ones. For the zwitterionic DPPC, on the otherhand, significant effects only occurred for negatively
charged NPs, including a decrease in elasticity [21]. The
authors discussed the dependence of the different parame-
ters, capping of nanoparticles and type of monolayer,
explaining why toxicity of a given nanoparticle cannot be
easily predicted and came to the conclusion that namely
the charge of the capping agents is crucial for the inter-
action of charged NPs with the cell membrane [21]. They
emphasize that more systematic studies probing not
only electrostatic but also hydrophobic and other types
of interaction are needed to better predict toxicity of
nanoparticles in future. The functional impact of Au-NPs
on B-lymphocytes, was investigated by Sharma M et al.,
using a murine B-lymphocyte cell line (CH12.LX), [22].
The scientists treated B-lymphocytes with citrate-stabi-
lized 10 nm Au-NPs and observed activation of an NF-κB-
regulated luciferase reporter, which correlated with altered
B lymphocyte function (i.e. increased antibody expression).
They suppose that Au-NPs could interact with intracellu-
lar components of the NF-κB signaling pathway after
passed through the cellular membrane, which was shown
by TEM imaging. To support this theory, Sharma et al.
showed, using immune-electrophoresis, that IKKα and
IKKβ can bind specifically to Au-NPs, based on their in-
herent property to bind to –thiol groups, when CH12.LX
lysate is exposed to 10 nmAu-NPs [22]. The authors dis-
cuss that altered NF-κB signaling and cellular function in
B-lymphocytes suggests a potential for off-target effects
with in vivo applications of gold nanomaterials. Tsyusko
et al., an US-American group of scientists from Lexington,
Kentucky, examined the in vivo particle-specific genomic
toxicity of Au-NPs to Caenorhabditis elegans [23]. Therefor
the scientists exposed nematodes to 4-nm citrate-coated
Au-NPs at a concentration resulting in 10% mortality (5.9
mg/L). Analysis of the toxicogenomic response via whole
genome microarray, they identified significant differential
expression of 797 genes. The authors independently con-
firmed the levels of expression for five genes (apl-1, dyn-1,
act-5, abu-11, and hsp-4) with qRT-PCR and identified
seven common biological pathways associated with 38 of
these genes [23]. They observed up-regulation of 26 pqn/
abu genes from noncanonical unfolded protein response
(UPR) pathways and molecular chaperones (hsp-16.1,
hsp-70, hsp-3, and hsp-4) which are likely indicative of
endoplasmic reticulum stress. Furthermore Tsyusko et al.
discuss involvement of the genes from this pathway in a
protective mechanism against Au-NPs, as a mutant from
noncanonical UPR (pgn-5) shows increased sensitivity to
Au-NPs. The finding that endocytosis mutants (chc-1 and
rme-2) significantly respond to Au-NPs was interpreted as
evidence for endocytosis pathways being induced by
Au-NPs. The authors concentrate their observations
mentioning Au-NPs causing adverse effects to C. elegans
by activating both general and specific biological pathways
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Au-NP toxicity and/or detoxification.
In another recent study to in-vivo-toxicity of AuNPs,
Perreault et al. investigated the toxicity of generation 0
PAMAM-coated gold nanoparticles (AuG0 NPs) in four
different biological models to determine how different
cellular systems are affected by PAMAm-coated NPs
[24]. The most common mechanisms by which PAMAM
dendrimers are thought to induce toxicity are membrane
disruption [25] and formation of reactive oxygen species
[18]. Therefore Perreault et al. evaluated toxicity in two
mammalian cell lines (Neuro 2A and Vero), in the green
alga Chlamydomonas reinhardtii and the bacteria Vibrio
fischeri. The scientists observed that AuG0 NP treat-
ments reduced cell metabolic activity in algal and bacter-
ial cells, measured by esterase enzymatic activity (C.
reinhardtii) and luminescence emission (V. fischeri) [24].
Contrariwise, almost no toxicity was observed in mam-
malian cells after treatment to AuG0 NPs. The authors
interpret the observed low toxicity of AuG0 Nps in
mammalian cells compared with the more sensitive algal
and bacterial cells on the one hand due to their specific
cellular structure and specific properties (i.e. higher
amphiphilicity and fluidity) and on the other hand with
possible modifications of the surface properties of NPs
in the cell culture medium, used for the mammalian cell
lines [24]. The authors recommend taking these obser-
vations into account when designing PAMAM NPs for
applications that may lead to their introduction in the
environment. To investigate lung toxicity of airborne
nanomaterials and its dependency on particle size, Schulz
et al. have investigated the genotoxic effects of 18 μg gold
nanomaterials of the same composition, but different sizes
(2,20 and 200 nm) administered by single intratracheal in-
stillation into the lung of male adult Wistar rats [26].
Chosen endpoints of this study were alkaline Comet assay
in lung tissue and micronucleation in polychromatic
erythrocytes of the bone marrow 72 h after single instilla-
tion. The authors could not detect relevant DNA damage
in the mentioned tests. Furthermore the measurement of
clinical pathology parameters in bronchoalveolar lavage
fluid (BALF) and blood indicated neither relevant local re-
actions in the animals' lungs nor adverse systemic effects.
The scientists come to the conclusion that under the con-
ditions of this study the different sized AuNPs tested were
non-genotoxic and showed no systemic and local adverse
effects at the given dose [26]. In another work regarding
size- dependent in vivo toxicity of AuNPs, Zhang et al. in-
vestigated the effects of 5, 10, 30 and 60 nm PEG-coated
gold nanoparticles in mice [27]. Therefore the mice re-
ceived an intraperitoneal injection of approximately 200 μL
of AuNPs solution at a dose of 4000 μg/kg. 28 days after
administration, the scientists evaluated animal survival,
bodyweight, biodistribution, bloodchemistry, biochemistryand characteristics on transmission electron microscopy.
Neither an obvious decrease in body weight could not be
detected, nor appreciable toxicity. But the authors ob-
served that Accumulation of AuNPs in different organs
was size dependent. 5 nm and 10 nm particles preferen-
tially accumulated in the liver and 30 nm particles in the
spleen. Accumulation of 5, 10, 30 and 60 nm particles in
the blood and bone marrow was proved by transmission
electron microscopy. Spleen index and thymus index were
increased, probably due to an affection of the immune sys-
tem by small nanoparticles. Whilst the 10 nm gold parti-
cles induced an increase in white blood cells, 5 nm and
30 nm particles induced a decrease in white blood cells
and red blood cells. A significant increase in alanine trans-
aminase and aspartate transaminase levels was caused by
the 10 nm and 60 nm PEG-coated AuNPs, indicating a
damage to the liver. The authors conclude that in vivo
toxicity of PEG-coated gold particles in mice is complex
but not strictly size-dependent. The toxicity of 10 nm and
60 nm particles was higher than that of 5 nm and 30 nm
particles [27].
Conclusion
This review of the recent published literature shows that
the potential toxic impact of AuNPs may be multisided
and is hard to predict. Beside particles size, also surface
chemistry and charged surface functional groups play a
crucial role in determining genotoxic-, mutagenic- or cell
toxic effects. Hence experimentally acquired knowledge
about size-dependent toxic effects, surface properties of
AuNPs and their eventually expected modifications in bio-
logical systems are essential to predict the impacts of
AuNPs in vivo and to reduce the hazard potential for
humans in the long run.
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